Comprehensive Assessment of Multiple Products (CAMP)

NCT07276347 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2026-04-13

No results posted yet for this study

Summary

The aim of this study is to assess contact lens performance and acceptance.

Conditions

  • Hyperopia
  • Myopia

Interventions

DEVICE

somofilcon A lens

Participants will be randomized to wear somofilcon A soft contact lens for 10 hours.

DEVICE

stenfilcon A lens

Participants will be randomized to wear stenfilcon A soft contact lens for 10 hours.

DEVICE

fanfilcon A lens

Participants will be randomized to wear fanfilcon A soft contact lens for 10 hours.

DEVICE

comfilcon A lens

Participants will be randomized to wear comfilcon A soft contact lens for 10 hours.

DEVICE

verofilcon A lens

Participants will be randomized to wear verofilcon A soft contact lens for 10 hours.

DEVICE

serafilcon A lens

Participants will be randomized to wear serafilcon A soft contact lens for 10 hours.

DEVICE

lehfilcon A lens

Participants will be randomized to wear lehfilcon A soft contact lens for 10 hours.

DEVICE

delefilcon A lens

Participants will be randomized to wear delefilcon A soft contact lens for 10 hours.

DEVICE

senofilcon A daily disposable lens

Participants will be randomized to wear senofilcon A soft contact lens for 10 hours.

DEVICE

senofilcon A with blue light technology lens

Participants will be randomized to wear senofilcon A soft contact lens for 10 hours.

DEVICE

senofilcon A bi-weekly lens

Participants will be randomized to wear senofilcon A soft contact lens for 10 hours.

DEVICE

samfilcon A lens

Participants will be randomized to wear samfilcon A soft contact lens for 10 hours.

DEVICE

kalilfilcon A lens

Participants will be randomized to wear kalifilcon A soft contact lens for 10 hours.

Sponsors & Collaborators

  • CooperVision International Limited (CVIL)

    lead INDUSTRY

Principal Investigators

  • Pete Kollbaum, OD, PhD · Indiana University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-12
Primary Completion
2025-12-17
Completion
2025-12-17
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07276347 on ClinicalTrials.gov